139 related articles for article (PubMed ID: 34379814)
1. Touching tumour-infiltrating lymphocytes in low-risk ductal carcinoma in situ (DCIS) correlate with upgrading to high-grade DCIS.
Khoury T; Quinn M; Tian W; Yan L; Zhan H
Histopathology; 2022 Jan; 80(2):291-303. PubMed ID: 34379814
[TBL] [Abstract][Full Text] [Related]
2. Tumour-infiltrating lymphocytes in ductal carcinoma in situ (DCIS)-assessment with three different methodologies and correlation with Oncotype DX DCIS Score.
Komforti M; Badve SS; Harmon B; Lo Y; Fineberg S
Histopathology; 2020 Nov; 77(5):749-759. PubMed ID: 32557780
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of tumor-infiltrating lymphocytes in ductal carcinoma in situ of the breast.
Toss MS; Miligy I; Al-Kawaz A; Alsleem M; Khout H; Rida PC; Aneja R; Green AR; Ellis IO; Rakha EA
Mod Pathol; 2018 Aug; 31(8):1226-1236. PubMed ID: 29559742
[TBL] [Abstract][Full Text] [Related]
4. Tumor-Infiltrating Lymphocytes in a Contemporary Cohort of Women with Ductal Carcinoma In Situ (DCIS).
Darvishian F; Ozerdem U; Adams S; Chun J; Pirraglia E; Kaplowitz E; Guth A; Axelrod D; Shapiro R; Price A; Troxel A; Schnabel F; Roses D
Ann Surg Oncol; 2019 Oct; 26(10):3337-3343. PubMed ID: 31240590
[TBL] [Abstract][Full Text] [Related]
5. Prognostic and predictive significance of tumor infiltrating lymphocytes for ductal carcinoma in situ.
Xu FF; Zheng SF; Xu C; Cai G; Wang SB; Qi WX; Wang CF; Chen JY; Lu C
Oncoimmunology; 2021 Mar; 10(1):1875637. PubMed ID: 33796401
[TBL] [Abstract][Full Text] [Related]
6. Analysis of tumour-infiltrating lymphocytes reveals two new biologically different subgroups of breast ductal carcinoma in situ.
Beguinot M; Dauplat MM; Kwiatkowski F; Lebouedec G; Tixier L; Pomel C; Penault-Llorca F; Radosevic-Robin N
BMC Cancer; 2018 Feb; 18(1):129. PubMed ID: 29394917
[TBL] [Abstract][Full Text] [Related]
7. The prevalence and clinical relevance of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ of the breast.
Pruneri G; Lazzeroni M; Bagnardi V; Tiburzio GB; Rotmensz N; DeCensi A; Guerrieri-Gonzaga A; Vingiani A; Curigliano G; Zurrida S; Bassi F; Salgado R; Van den Eynden G; Loi S; Denkert C; Bonanni B; Viale G
Ann Oncol; 2017 Feb; 28(2):321-328. PubMed ID: 28426105
[TBL] [Abstract][Full Text] [Related]
8. Tumour-infiltrating lymphocytes add prognostic information for patients with low-risk DCIS: findings from the SweDCIS randomised radiotherapy trial.
Schiza A; Thurfjell V; Stenmark Tullberg A; Olofsson H; Lindberg A; Holmberg E; Bremer T; Micke P; Karlsson P; Wärnberg F; Strell C
Eur J Cancer; 2022 Jun; 168():128-137. PubMed ID: 35236568
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of tumour infiltrating B lymphocytes in breast ductal carcinoma in situ.
Miligy I; Mohan P; Gaber A; Aleskandarany MA; Nolan CC; Diez-Rodriguez M; Mukherjee A; Chapman C; Ellis IO; Green AR; Rakha EA
Histopathology; 2017 Aug; 71(2):258-268. PubMed ID: 28326600
[TBL] [Abstract][Full Text] [Related]
10. The prognostic significance of immune microenvironment in breast ductal carcinoma in situ.
Toss MS; Abidi A; Lesche D; Joseph C; Mahale S; Saunders H; Kader T; Miligy IM; Green AR; Gorringe KL; Rakha EA
Br J Cancer; 2020 May; 122(10):1496-1506. PubMed ID: 32203210
[TBL] [Abstract][Full Text] [Related]
11. Higher densities of tumour-infiltrating lymphocytes and CD4
Thike AA; Chen X; Koh VCY; Binte Md Nasir ND; Yeong JPS; Bay BH; Tan PH
Histopathology; 2020 May; 76(6):852-864. PubMed ID: 31883279
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of tumor-infiltrating lymphocytes in DCIS: a meta-analysis.
Wu SL; Yu X; Mao X; Jin F
BMC Cancer; 2022 Jul; 22(1):782. PubMed ID: 35843951
[TBL] [Abstract][Full Text] [Related]
13. An Examination of the Local Cellular Immune Response to Examples of Both Ductal Carcinoma In Situ (DCIS) of the Breast and DCIS With Microinvasion, With Emphasis on Tertiary Lymphoid Structures and Tumor Infiltrating Lymphoctytes.
Kim A; Heo SH; Kim YA; Gong G; Jin Lee H
Am J Clin Pathol; 2016 Jul; 146(1):137-44. PubMed ID: 27402610
[TBL] [Abstract][Full Text] [Related]
14. Feasibility of the Less Is More Approach in Treating Low-Risk Ductal Carcinoma In Situ Diagnosed on Core Needle Biopsy: Ten-Year Review of Ductal Carcinoma In Situ Upgraded to Invasion at Surgery.
Podoll MB; Reisenbichler ES; Roland L; Bruner A; Mizuguchi S; Sanders MAG
Arch Pathol Lab Med; 2018 Sep; 142(9):1120-1126. PubMed ID: 29582675
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological characteristics and prognostic analysis of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ (DCIS) and DCIS with microinvasion (DCIS-Mi) of the breast.
Jia H; Zhao P; Chen Z; Wang G; Dong X; Xing X; Tan X; Wang C
Breast Cancer Res Treat; 2022 May; 193(1):111-120. PubMed ID: 35260954
[TBL] [Abstract][Full Text] [Related]
16. Ductal Carcinoma In Situ - Quo Vadis?
Peltecu G
Chirurgia (Bucur); 2021 Dec; 116(5 Suppl):S5-S6. PubMed ID: 34967322
[TBL] [Abstract][Full Text] [Related]
17. Prognostic role of immune infiltrates in breast ductal carcinoma in situ.
Chen XY; Yeong J; Thike AA; Bay BH; Tan PH
Breast Cancer Res Treat; 2019 Aug; 177(1):17-27. PubMed ID: 31134489
[TBL] [Abstract][Full Text] [Related]
18. High EZH2 expression in ductal carcinoma in situ diagnosed on breast core needle biopsy is an independent predictive factor for upgrade on surgical excision.
Genco IS; Ozgultekin B; Hosseini H; Hackman K; Ferreira L; Santagada E; Wahl S; Hajiyeva S
Pathol Res Pract; 2020 Dec; 216(12):153283. PubMed ID: 33197837
[TBL] [Abstract][Full Text] [Related]
19. The PD-1/PD-L1 Axis in HER2+ Ductal Carcinoma In Situ (DCIS) of the Breast.
Ubago JM; Blanco LZ; Shen T; Siziopikou KP
Am J Clin Pathol; 2019 Jul; 152(2):169-176. PubMed ID: 30984969
[TBL] [Abstract][Full Text] [Related]
20. Macrophage density is an adverse prognosticator for ipsilateral recurrence in ductal carcinoma in situ.
Darvishian F; Wu Y; Ozerdem U; Chun J; Adams S; Guth A; Axelrod D; Shapiro R; Troxel AB; Schnabel F; Roses D
Breast; 2022 Aug; 64():35-40. PubMed ID: 35489232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
